Inexpensive Anti-Inflammatory Pill Could Reduce Risk of Heart Attack and Stroke

In this analysis, researchers evaluated the impact of low-dose colchicine, a long-established gout treatment, and found no evidence of an increase in serious adverse effects.

Chronic, low-level inflammation plays a major role in heart disease and often contributes to repeated cardiovascular events, including heart attacks and strokes. Because colchicine works by reducing inflammatory activity, scientists are exploring its potential benefits for individuals already living with heart conditions.

 

https://scitechdaily.com/this-inexpensive-anti-inflammatory-pill-could-reduce-risk-of-heart-attack-and-stroke/

Scientific news

  • High Salivary Aldosterone Can Signal Future Heart Disease Researchers cross-sectionally compared the salivary free AldAR among men with coronary heart disease, essential hypertension, and normotension and prospectively evaluated whether the AldAR could predict the risk for coronary heart disease.
  • Weight Gain Risks: The Ultraprocessed Food Connection Researchers analyzed data from 24,453 Brazilian adults (79.7% women) in the NutriNet Brasil cohort study, who were followed up for a median of 43.6 months, to assess the association between consumption of ultraprocessed foods and weight gain.
  • Low Vitamin D Levels Signal Increased Heart Risk in Seniors In older adults, lower levels of vitamin D metabolites and periostin, a protein involved in remodelling and repairing tissues, were linked to an increased cardiovascular (CV) risk. Low periostin levels were correlated with low vitamin D levels, and when all three markers were considered together, only the active form of vitamin D independently predicted the CV risk.
  • Mapping the evidence on mHealth interventions for cardiovascular event care in Africa: a scoping review The burden of cardiovascular disease in Africa is projected to increase significantly over the next decade, placing additional strain on already overburdened healthcare systems. Mobile health (mHealth) technologies represent a promising approach to addressing these challenges. This review analyzes the use of mHealth solutions in cardiovascular care in Africa.
  • Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia Genetic and epidemiological evidence indicates that triglyceride-rich lipoproteins are causal risk factors for atherosclerotic cardiovascular disease (ASCVD). Elevated levels of plasma triglyceride are common in patients who are diabetic or obese and contribute substantially to residual, ongoing risk of an ASCVD event in individuals on low-density lipoprotein (LDL)-lowering treatment.

Partners

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru